Home - Products - Others - Other Targets - 15,26-Dihydroxylanosta-7,9(11),24-trien-3-one

15,26-Dihydroxylanosta-7,9(11),24-trien-3-one

CAS No. 420781-85-7

15,26-Dihydroxylanosta-7,9(11),24-trien-3-one( —— )

Catalog No. M32555 CAS No. 420781-85-7

The fruit body of Ganoderma lucidum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 664 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    15,26-Dihydroxylanosta-7,9(11),24-trien-3-one
  • Note
    Research use only, not for human use.
  • Brief Description
    The fruit body of Ganoderma lucidum.
  • Description
    The fruit body of Ganoderma lucidum.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    420781-85-7
  • Formula Weight
    454.7
  • Molecular Formula
    C30H46O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • HQL-79

    HQL-79, a potent, selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor, highly selectively inhibits the synthesis of PGD2, and acts as an anti-allergic agent, with a Kd of 0.8 μM and an IC50 of 6 μM. Shows no obvious effect on COX-1, COX-2, m-PGES, or L-PGDS.

  • Isosilybin B

    Isosilybin B is a flavonolignan extracted from silymarin that exhibits anti-prostate cancer (PCA) activity, inhibits cancer cell proliferation, and contributes to G1-phase blockade and apoptosis.Isosilybin B induces degradation of the androgen receptor.

  • Praeruptorin E

    Praeruptorin C and E can relax swine coronary artery and decrease contractility in guinea-pig left atria, these effects are similar in many respects to those displayed by drugs that have calcium entry blocking activity.